Global Human Growth Hormone Market: Industry Analysis and Forecast (2019-2026): By Route of Administration, Distribution Channel, Application and Region.

Global Human Growth Hormone Market is expected to grow at a CAGR of 9% during the forecast period. Global Human Growth Hormone Market is expected to reach US$ 7.06 Bn. by2026. Global Human Growth Hormone Market To know about the Research Methodology :- Request Free Sample Report The report analyzes factors affecting the HGH market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The human growth hormone also helps in controlling muscle & bone growth, body fluids, sugar & fat metabolism, body composition, and recovery from injury. It also helps increase muscle strength & performance. However, lower or higher levels of growth hormone may affect the quality of life thereby growing the risks of diseases like high cholesterol levels, growth hormone deficiency, or poor bone density. Hospital pharmacy is expected to account for the largest XX% market share by 2026. Several hospital pharmacies are distributing drugs owing to the plummeting cost of human growth hormone drugs. Increased investments for the development of hospitals and advanced healthcare centers by the governments are some of the major growth factors of the segment. The report offers a brief analysis of the major regions in the market, namely, the APAC, Europe, North America, South America, and the Middle East & Africa. North America leads the global human growth hormone market, because of the increasing proportion of the aged population, high incidences of turner syndrome, short bowel syndrome, human growth hormone deficiency, and Noonan syndrome. Additionally, the high demand for human growth hormone drugs as a performance enhancer and anti-aging drug in North America is driving the growth of the HGH market in the region. The report also focuses on global major leading industry players of the global human growth hormone (HGH) market providing information like company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Novo Nordisk is a worldwide healthcare company that develops, manufactures, markets and distributes pharmaceuticals in 180+ countries globally. The firm mostly focuses on the development and marketing of biopharmaceuticals, Novo Nordisk has been a leader in the diabetes care segment for more than 90 years. A recent development in the market for human growth hormone (HGH) like in September 2018, a clinical-stage biopharmaceutical company, Lumos Pharma Inc, has recently announced that the company has acquired the license for LUM-201 from Ammonett Pharma LLC. Lumos. LUM-201 is an investigational verbally administered small molecule for promoting the secretion of growth hormone from the pituitary gland. The companies together have planned to recruit a Phase IIb trial in 2019 within the patients suffering from Pediatric Growth Hormone Deficiency. The objective of the report is to present comprehensive analysis of Global Human Growth Hormone Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers the all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers. The report also helps in understanding Global Human Growth Hormone Market dynamics, structure by analyzing the market segments, and project the Global Human Growth Hormone Market size. Clear representation of competitive analysis of key players by type, price, financial position, product portfolio, growth strategies, and regional presence in the Global Human Growth Hormone Market make the report investor’s guide.

Scope of the Global Human Growth Hormone Market: Inquire before buying

Global Human Growth Hormone Market, By Application

• Growth Hormone Deficiency • Prader-Willi Syndrome • Turner Syndrome • Small for Gestational Age • Idiopathic Short Stature • Others

Global Human Growth Hormone Market, By Route of Administration

• Intravenous • Intramuscular • Subcutaneous • Oral

Global Human Growth Hormone Market, By Distribution Channel

• Hospital Pharmacy • Retail Pharmacy • Clinics • Online Pharmacy

Global Human Growth Hormone Market, By Region

• North America • Asia Pacific • Europe • Middle East & Africa • South America

Key players operating in the Global Human Growth Hormone Market

• Novo Nordisk • Pfizer • Eli Lilly • Merck Serono • F. Hoffmann-La Roche • Ferring Pharmaceuticals • GeneScience Pharmaceuticals • Ipsen • LG Life Sciences • Sandoz International • Anhui Anke Biotechnology • BioPartners • Teva Pharmaceutical Industries • Novo Nordisk A/S • EMD Serono Inc. • AnkeBio Co. Ltd. • Genentech Inc.
Global Human Growth Hormone Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Human Growth Hormone Market Size, by Market Value (US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Human Growth Hormone Market Analysis and Forecast 6.1. Global Human Growth Hormone Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Human Growth Hormone Market Analysis and Forecast, By Route of Administration 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Human Growth Hormone Market Value Share Analysis, By Route of Administration 7.4. Global Human Growth Hormone Market Size (US$ Bn) Forecast, By Route of Administration 7.5. Global Human Growth Hormone Market Analysis, By Route of Administration 7.6. Global Human Growth Hormone Market Attractiveness Analysis, By Route of Administration 8. Global Human Growth Hormone Market Analysis and Forecast, By Distribution Channel 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Human Growth Hormone Market Value Share Analysis, By Distribution Channel 8.4. Global Human Growth Hormone Market Size (US$ Bn) Forecast, By Distribution Channel 8.5. Global Human Growth Hormone Market Analysis, By Distribution Channel 8.6. Global Human Growth Hormone Market Attractiveness Analysis, By Distribution Channel 9. Global Human Growth Hormone Market Analysis and Forecast, By Application 9.1. Introduction and Definition 9.2. Key Findings 9.3. Global Human Growth Hormone Market Value Share Analysis, By Application 9.4. Global Human Growth Hormone Market Size (US$ Bn) Forecast, By Application 9.5. Global Human Growth Hormone Market Analysis, By Application 9.6. Global Human Growth Hormone Market Attractiveness Analysis, By Application 10. Global Human Growth Hormone Market Analysis, by Region 10.1. Global Human Growth Hormone Market Value Share Analysis, by Region 10.2. Global Human Growth Hormone Market Size (US$ Bn) Forecast, by Region 10.3. Global Human Growth Hormone Market Attractiveness Analysis, by Region 11. North America Human Growth Hormone Market Analysis 11.1. Key Findings 11.2. North America Human Growth Hormone Market Overview 11.3. North America Human Growth Hormone Market Value Share Analysis, By Route of Administration 11.4. North America Human Growth Hormone Market Forecast, By Route of Administration 11.4.1. Intravenous 11.4.2. Intramuscular 11.4.3. Subcutaneous 11.4.4. Oral 11.5. North America Human Growth Hormone Market Value Share Analysis, By Distribution Channel 11.6. North America Human Growth Hormone Market Forecast, By Distribution Channel 11.6.1. Hospital Pharmacy 11.6.2. Retail Pharmacy 11.6.3. Clinics 11.6.4. Online Pharmacy 11.7. North America Human Growth Hormone Market Value Share Analysis, By Application 11.8. North America Human Growth Hormone Market Forecast, By Application 11.8.1. Growth Hormone Deficiency 11.8.2. Prader-Willi Syndrome 11.8.3. Turner Syndrome 11.8.4. Small for Gestational Age 11.8.5. Idiopathic Short Stature 11.8.6. Others 11.9. North America Human Growth Hormone Market Value Share Analysis, by Country 11.10. North America Human Growth Hormone Market Forecast, by Country 11.10.1. U.S. 11.10.2. Canada 11.11. North America Human Growth Hormone Market Analysis, by Country 11.12. U.S. Human Growth Hormone Market Forecast, By Route of Administration 11.12.1. Intravenous 11.12.2. Intramuscular 11.12.3. Subcutaneous 11.12.4. Oral 11.13. U.S. Human Growth Hormone Market Forecast, By Distribution Channel 11.13.1. Hospital Pharmacy 11.13.2. Retail Pharmacy 11.13.3. Clinics 11.13.4. Online Pharmacy 11.14. U.S. Human Growth Hormone Market Forecast, By Application 11.14.1. Growth Hormone Deficiency 11.14.2. Prader-Willi Syndrome 11.14.3. Turner Syndrome 11.14.4. Small for Gestational Age 11.14.5. Idiopathic Short Stature 11.14.6. Others 11.15. Canada Human Growth Hormone Market Forecast, By Route of Administration 11.15.1. Intravenous 11.15.2. Intramuscular 11.15.3. Subcutaneous 11.15.4. Oral 11.16. Canada Human Growth Hormone Market Forecast, By Distribution Channel 11.16.1. Hospital Pharmacy 11.16.2. Retail Pharmacy 11.16.3. Clinics 11.16.4. Online Pharmacy 11.17. Canada Human Growth Hormone Market Forecast, By Application 11.17.1. Growth Hormone Deficiency 11.17.2. Prader-Willi Syndrome 11.17.3. Turner Syndrome 11.17.4. Small for Gestational Age 11.17.5. Idiopathic Short Stature 11.17.6. Others 11.18. North America Human Growth Hormone Market Attractiveness Analysis 11.18.1. By Route of Administration 11.18.2. By Distribution Channel 11.18.3. By Application 11.19. PEST Analysis 11.20. Key Trends 11.21. Key Developments 12. Europe Human Growth Hormone Market Analysis 12.1. Key Findings 12.2. Europe Human Growth Hormone Market Overview 12.3. Europe Human Growth Hormone Market Value Share Analysis, By Route of Administration 12.4. Europe Human Growth Hormone Market Forecast, By Route of Administration 12.4.1. Intravenous 12.4.2. Intramuscular 12.4.3. Subcutaneous 12.4.4. Oral 12.5. Europe Human Growth Hormone Market Value Share Analysis, By Distribution Channel 12.6. Europe Human Growth Hormone Market Forecast, By Distribution Channel 12.6.1. Hospital Pharmacy 12.6.2. Retail Pharmacy 12.6.3. Clinics 12.6.4. Online Pharmacy 12.7. Europe Human Growth Hormone Market Value Share Analysis, By Application 12.8. Europe Human Growth Hormone Market Forecast, By Application 12.8.1. Growth Hormone Deficiency 12.8.2. Prader-Willi Syndrome 12.8.3. Turner Syndrome 12.8.4. Small for Gestational Age 12.8.5. Idiopathic Short Stature 12.8.6. Others 12.9. Europe Human Growth Hormone Market Value Share Analysis, by Country 12.10. Europe Human Growth Hormone Market Forecast, by Country 12.10.1. Germany 12.10.2. U.K. 12.10.3. France 12.10.4. Italy 12.10.5. Spain 12.10.6. Rest of Europe 12.11. Europe Human Growth Hormone Market Analysis, by Country 12.12. Germany Human Growth Hormone Market Forecast, By Route of Administration 12.12.1. Intravenous 12.12.2. Intramuscular 12.12.3. Subcutaneous 12.12.4. Oral 12.13. Germany Human Growth Hormone Market Forecast, By Distribution Channel 12.13.1. Hospital Pharmacy 12.13.2. Retail Pharmacy 12.13.3. Clinics 12.13.4. Online Pharmacy 12.14. Germany Human Growth Hormone Market Forecast, By Application 12.14.1. Growth Hormone Deficiency 12.14.2. Prader-Willi Syndrome 12.14.3. Turner Syndrome 12.14.4. Small for Gestational Age 12.14.5. Idiopathic Short Stature 12.14.6. Others 12.15. U.K. Human Growth Hormone Market Forecast, By Route of Administration 12.15.1. Intravenous 12.15.2. Intramuscular 12.15.3. Subcutaneous 12.15.4. Oral 12.16. U.K. Human Growth Hormone Market Forecast, By Distribution Channel 12.16.1. Hospital Pharmacy 12.16.2. Retail Pharmacy 12.16.3. Clinics 12.16.4. Online Pharmacy 12.17. U.K. Human Growth Hormone Market Forecast, By Application 12.17.1. Growth Hormone Deficiency 12.17.2. Prader-Willi Syndrome 12.17.3. Turner Syndrome 12.17.4. Small for Gestational Age 12.17.5. Idiopathic Short Stature 12.17.6. Others 12.18. France Human Growth Hormone Market Forecast, By Route of Administration 12.18.1. Intravenous 12.18.2. Intramuscular 12.18.3. Subcutaneous 12.18.4. Oral 12.19. France Human Growth Hormone Market Forecast, By Distribution Channel 12.19.1. Hospital Pharmacy 12.19.2. Retail Pharmacy 12.19.3. Clinics 12.19.4. Online Pharmacy 12.20. France Human Growth Hormone Market Forecast, By Application 12.20.1. Growth Hormone Deficiency 12.20.2. Prader-Willi Syndrome 12.20.3. Turner Syndrome 12.20.4. Small for Gestational Age 12.20.5. Idiopathic Short Stature 12.20.6. Others 12.21. Italy Human Growth Hormone Market Forecast, By Route of Administration 12.21.1. Intravenous 12.21.2. Intramuscular 12.21.3. Subcutaneous 12.21.4. Oral 12.22. Italy Human Growth Hormone Market Forecast, By Distribution Channel 12.22.1. Hospital Pharmacy 12.22.2. Retail Pharmacy 12.22.3. Clinics 12.22.4. Online Pharmacy 12.23. Italy Human Growth Hormone Market Forecast, By Application 12.23.1. Growth Hormone Deficiency 12.23.2. Prader-Willi Syndrome 12.23.3. Turner Syndrome 12.23.4. Small for Gestational Age 12.23.5. Idiopathic Short Stature 12.23.6. Others 12.24. Spain Human Growth Hormone Market Forecast, By Route of Administration 12.24.1. Intravenous 12.24.2. Intramuscular 12.24.3. Subcutaneous 12.24.4. Oral 12.25. Spain Human Growth Hormone Market Forecast, By Distribution Channel 12.25.1. Hospital Pharmacy 12.25.2. Retail Pharmacy 12.25.3. Clinics 12.25.4. Online Pharmacy 12.26. Spain Human Growth Hormone Market Forecast, By Application 12.26.1. Growth Hormone Deficiency 12.26.2. Prader-Willi Syndrome 12.26.3. Turner Syndrome 12.26.4. Small for Gestational Age 12.26.5. Idiopathic Short Stature 12.26.6. Others 12.27. Rest of Europe Human Growth Hormone Market Forecast, By Route of Administration 12.27.1. Intravenous 12.27.2. Intramuscular 12.27.3. Subcutaneous 12.27.4. Oral 12.28. Rest of Europe Human Growth Hormone Market Forecast, By Distribution Channel 12.28.1. Hospital Pharmacy 12.28.2. Retail Pharmacy 12.28.3. Clinics 12.28.4. Online Pharmacy 12.29. Rest Of Europe Human Growth Hormone Market Forecast, By Application 12.29.1. Growth Hormone Deficiency 12.29.2. Prader-Willi Syndrome 12.29.3. Turner Syndrome 12.29.4. Small for Gestational Age 12.29.5. Idiopathic Short Stature 12.29.6. Others 12.30. Europe Human Growth Hormone Market Attractiveness Analysis 12.30.1. By Route of Administration 12.30.2. By Distribution Channel 12.30.3. By Application 12.31. PEST Analysis 12.32. Key Trends 12.33. Key Developments 13. Asia Pacific Human Growth Hormone Market Analysis 13.1. Key Findings 13.2. Asia Pacific Human Growth Hormone Market Overview 13.3. Asia Pacific Human Growth Hormone Market Value Share Analysis, By Route of Administration 13.4. Asia Pacific Human Growth Hormone Market Forecast, By Route of Administration 13.4.1. Intravenous 13.4.2. Intramuscular 13.4.3. Subcutaneous 13.4.4. Oral 13.5. Asia Pacific Human Growth Hormone Market Value Share Analysis, By Distribution Channel 13.6. Asia Pacific Human Growth Hormone Market Forecast, By Distribution Channel 13.6.1. Hospital Pharmacy 13.6.2. Retail Pharmacy 13.6.3. Clinics 13.6.4. Online Pharmacy 13.7. Asia Pacific Human Growth Hormone Market Value Share Analysis, By Application 13.8. Asia Pacific Human Growth Hormone Market Forecast, By Application 13.8.1. Growth Hormone Deficiency 13.8.2. Prader-Willi Syndrome 13.8.3. Turner Syndrome 13.8.4. Small for Gestational Age 13.8.5. Idiopathic Short Stature 13.8.6. Others 13.9. Asia Pacific Human Growth Hormone Market Value Share Analysis, by Country 13.10. Asia Pacific Human Growth Hormone Market Forecast, by Country 13.10.1. China 13.10.2. India 13.10.3. Japan 13.10.4. ASEAN 13.10.5. Rest of Asia Pacific 13.11. Asia Pacific Human Growth Hormone Market Analysis, by Country 13.12. China Human Growth Hormone Market Forecast, By Route of Administration 13.12.1. Intravenous 13.12.2. Intramuscular 13.12.3. Subcutaneous 13.12.4. Oral 13.13. China Human Growth Hormone Market Forecast, By Distribution Channel 13.13.1. Hospital Pharmacy 13.13.2. Retail Pharmacy 13.13.3. Clinics 13.13.4. Online Pharmacy 13.14. China Human Growth Hormone Market Forecast, By Application 13.14.1. Growth Hormone Deficiency 13.14.2. Prader-Willi Syndrome 13.14.3. Turner Syndrome 13.14.4. Small for Gestational Age 13.14.5. Idiopathic Short Stature 13.14.6. Others 13.15. India Human Growth Hormone Market Forecast, By Route of Administration 13.15.1. Intravenous 13.15.2. Intramuscular 13.15.3. Subcutaneous 13.15.4. Oral 13.16. India Human Growth Hormone Market Forecast, By Distribution Channel 13.16.1. Hospital Pharmacy 13.16.2. Retail Pharmacy 13.16.3. Clinics 13.16.4. Online Pharmacy 13.17. India Human Growth Hormone Market Forecast, By Application 13.17.1. Growth Hormone Deficiency 13.17.2. Prader-Willi Syndrome 13.17.3. Turner Syndrome 13.17.4. Small for Gestational Age 13.17.5. Idiopathic Short Stature 13.17.6. Others 13.18. Japan Human Growth Hormone Market Forecast, By Route of Administration 13.18.1. Intravenous 13.18.2. Intramuscular 13.18.3. Subcutaneous 13.18.4. Oral 13.19. Japan Human Growth Hormone Market Forecast, By Distribution Channel 13.19.1. Hospital Pharmacy 13.19.2. Retail Pharmacy 13.19.3. Clinics 13.19.4. Online Pharmacy 13.20. Japan Human Growth Hormone Market Forecast, By Application 13.20.1. Growth Hormone Deficiency 13.20.2. Prader-Willi Syndrome 13.20.3. Turner Syndrome 13.20.4. Small for Gestational Age 13.20.5. Idiopathic Short Stature 13.20.6. Others 13.21. ASEAN Human Growth Hormone Market Forecast, By Route of Administration 13.21.1. Intravenous 13.21.2. Intramuscular 13.21.3. Subcutaneous 13.21.4. Oral 13.22. ASEAN Human Growth Hormone Market Forecast, By Distribution Channel 13.22.1. Hospital Pharmacy 13.22.2. Retail Pharmacy 13.22.3. Clinics 13.22.4. Online Pharmacy 13.23. ASEAN Human Growth Hormone Market Forecast, By Application 13.23.1. Growth Hormone Deficiency 13.23.2. Prader-Willi Syndrome 13.23.3. Turner Syndrome 13.23.4. Small for Gestational Age 13.23.5. Idiopathic Short Stature 13.23.6. Others 13.24. Rest of Asia Pacific Human Growth Hormone Market Forecast, By Route of Administration 13.24.1. Intravenous 13.24.2. Intramuscular 13.24.3. Subcutaneous 13.24.4. Oral 13.25. Rest of Asia Pacific Human Growth Hormone Market Forecast, By Distribution Channel 13.25.1. Hospital Pharmacy 13.25.2. Retail Pharmacy 13.25.3. Clinics 13.25.4. Online Pharmacy 13.26. Rest of Asia Pacific Human Growth Hormone Market Forecast, By Application 13.26.1. Growth Hormone Deficiency 13.26.2. Prader-Willi Syndrome 13.26.3. Turner Syndrome 13.26.4. Small for Gestational Age 13.26.5. Idiopathic Short Stature 13.26.6. Others 13.27. Asia Pacific Human Growth Hormone Market Attractiveness Analysis 13.27.1. By Route of Administration 13.27.2. By Distribution Channel 13.27.3. By Application 13.28. PEST Analysis 13.29. Key Trends 13.30. Key Developments 14. Middle East & Africa Human Growth Hormone Market Analysis 14.1. Key Findings 14.2. Middle East & Africa Human Growth Hormone Market Overview 14.3. Middle East & Africa Human Growth Hormone Market Value Share Analysis, By Route of Administration 14.4. Middle East & Africa Human Growth Hormone Market Forecast, By Route of Administration 14.4.1. Intravenous 14.4.2. Intramuscular 14.4.3. Subcutaneous 14.4.4. Oral 14.5. Middle East & Africa Human Growth Hormone Market Value Share Analysis, By Distribution Channel 14.6. Middle East & Africa Human Growth Hormone Market Forecast, By Distribution Channel 14.6.1. Hospital Pharmacy 14.6.2. Retail Pharmacy 14.6.3. Clinics 14.6.4. Online Pharmacy 14.7. Middle East & Africa Human Growth Hormone Market Value Share Analysis, By Application 14.8. Middle East & Africa Human Growth Hormone Market Forecast, By Application 14.8.1. Growth Hormone Deficiency 14.8.2. Prader-Willi Syndrome 14.8.3. Turner Syndrome 14.8.4. Small for Gestational Age 14.8.5. Idiopathic Short Stature 14.8.6. Others 14.9. Middle East & Africa Human Growth Hormone Market Value Share Analysis, by Country 14.10. Middle East & Africa Human Growth Hormone Market Forecast, by Country 14.10.1. GCC 14.10.2. South Africa 14.10.3. Rest of Middle East & Africa 14.11. Middle East & Africa Human Growth Hormone Market Analysis, by Country 14.12. GCC Human Growth Hormone Market Forecast, By Route of Administration 14.12.1. Intravenous 14.12.2. Intramuscular 14.12.3. Subcutaneous 14.12.4. Oral 14.13. GCC Human Growth Hormone Market Forecast, By Distribution Channel 14.13.1. Hospital Pharmacy 14.13.2. Retail Pharmacy 14.13.3. Clinics 14.13.4. Online Pharmacy 14.14. GCC Human Growth Hormone Market Forecast, By Application 14.14.1. Growth Hormone Deficiency 14.14.2. Prader-Willi Syndrome 14.14.3. Turner Syndrome 14.14.4. Small for Gestational Age 14.14.5. Idiopathic Short Stature 14.14.6. Others 14.15. South Africa Human Growth Hormone Market Forecast, By Route of Administration 14.15.1. Intravenous 14.15.2. Intramuscular 14.15.3. Subcutaneous 14.15.4. Oral 14.16. South Africa Human Growth Hormone Market Forecast, By Distribution Channel 14.16.1. Hospital Pharmacy 14.16.2. Retail Pharmacy 14.16.3. Clinics 14.16.4. Online Pharmacy 14.17. South Africa Human Growth Hormone Market Forecast, By Application 14.17.1. Growth Hormone Deficiency 14.17.2. Prader-Willi Syndrome 14.17.3. Turner Syndrome 14.17.4. Small for Gestational Age 14.17.5. Idiopathic Short Stature 14.17.6. Others 14.18. Rest of Middle East & Africa Human Growth Hormone Market Forecast, By Route of Administration 14.18.1. Intravenous 14.18.2. Intramuscular 14.18.3. Subcutaneous 14.18.4. Oral 14.19. Rest of Middle East & Africa Human Growth Hormone Market Forecast, By Distribution Channel 14.19.1. Hospital Pharmacy 14.19.2. Retail Pharmacy 14.19.3. Clinics 14.19.4. Online Pharmacy 14.20. Rest of Middle East & Africa Human Growth Hormone Market Forecast, By Application 14.20.1. Growth Hormone Deficiency 14.20.2. Prader-Willi Syndrome 14.20.3. Turner Syndrome 14.20.4. Small for Gestational Age 14.20.5. Idiopathic Short Stature 14.20.6. Others 14.21. Middle East & Africa Human Growth Hormone Market Attractiveness Analysis 14.21.1. By Route of Administration 14.21.2. By Distribution Channel 14.21.3. By Application 14.22. PEST Analysis 14.23. Key Trends 14.24. Key Developments 15. South America Human Growth Hormone Market Analysis 15.1. Key Findings 15.2. South America Human Growth Hormone Market Overview 15.3. South America Human Growth Hormone Market Value Share Analysis, By Route of Administration 15.4. South America Human Growth Hormone Market Forecast, By Route of Administration 15.4.1. Intravenous 15.4.2. Intramuscular 15.4.3. Subcutaneous 15.4.4. Oral 15.5. South America Human Growth Hormone Market Value Share Analysis, By Distribution Channel 15.6. South America Human Growth Hormone Market Forecast, By Distribution Channel 15.6.1. Hospital Pharmacy 15.6.2. Retail Pharmacy 15.6.3. Clinics 15.6.4. Online Pharmacy 15.7. South America Human Growth Hormone Market Value Share Analysis, By Application 15.8. South America Human Growth Hormone Market Forecast, By Application 15.8.1. Growth Hormone Deficiency 15.8.2. Prader-Willi Syndrome 15.8.3. Turner Syndrome 15.8.4. Small for Gestational Age 15.8.5. Idiopathic Short Stature 15.8.6. Others 15.9. South America Human Growth Hormone Market Value Share Analysis, by Country 15.10. South America Human Growth Hormone Market Forecast, by Country 15.10.1. Brazil 15.10.2. Mexico 15.10.3. Rest of South America 15.11. South America Human Growth Hormone Market Analysis, by Country 15.12. Brazil Human Growth Hormone Market Forecast, By Route of Administration 15.12.1. Intravenous 15.12.2. Intramuscular 15.12.3. Subcutaneous 15.12.4. Oral 15.13. Brazil Human Growth Hormone Market Forecast, By Distribution Channel 15.13.1. Hospital Pharmacy 15.13.2. Retail Pharmacy 15.13.3. Clinics 15.13.4. Online Pharmacy 15.14. Brazil Human Growth Hormone Market Forecast, By Application 15.14.1. Growth Hormone Deficiency 15.14.2. Prader-Willi Syndrome 15.14.3. Turner Syndrome 15.14.4. Small for Gestational Age 15.14.5. Idiopathic Short Stature 15.14.6. Others 15.15. Mexico Human Growth Hormone Market Forecast, By Route of Administration 15.15.1. Intravenous 15.15.2. Intramuscular 15.15.3. Subcutaneous 15.15.4. Oral 15.16. Mexico Human Growth Hormone Market Forecast, By Distribution Channel 15.16.1. Hospital Pharmacy 15.16.2. Retail Pharmacy 15.16.3. Clinics 15.16.4. Online Pharmacy 15.17. Mexico Human Growth Hormone Market Forecast, By Application 15.17.1. Growth Hormone Deficiency 15.17.2. Prader-Willi Syndrome 15.17.3. Turner Syndrome 15.17.4. Small for Gestational Age 15.17.5. Idiopathic Short Stature 15.17.6. Others 15.18. Rest of South America Human Growth Hormone Market Forecast, By Route of Administration 15.18.1. Intravenous 15.18.2. Intramuscular 15.18.3. Subcutaneous 15.18.4. Oral 15.19. Rest of South America Human Growth Hormone Market Forecast, By Distribution Channel 15.19.1. Hospital Pharmacy 15.19.2. Retail Pharmacy 15.19.3. Clinics 15.19.4. Online Pharmacy 15.20. Rest of South America Human Growth Hormone Market Forecast, By Application 15.20.1. Growth Hormone Deficiency 15.20.2. Prader-Willi Syndrome 15.20.3. Turner Syndrome 15.20.4. Small for Gestational Age 15.20.5. Idiopathic Short Stature 15.20.6. Others 15.21. South America Human Growth Hormone Market Attractiveness Analysis 15.21.1. By Route of Administration 15.21.2. By Distribution Channel 15.21.3. By Application 15.22. PEST Analysis 15.23. Key Trends 15.24. Key Developments 16. Company Profiles 16.1. Market Share Analysis, by Company 16.2. Competition Matrix 16.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 16.2.2. New Product Launches and Product Enhancements 16.2.3. Market Consolidation 16.2.3.1. M&A by Regions, Investment and Applications 16.2.3.2. M&A Key Players, Forward Integration and Backward Integration 16.3. Company Profiles: Key Players 16.3.1. Novo Nordisk 16.3.1.1. Company Overview 16.3.1.2. Financial Overview 16.3.1.3. Product Portfolio 16.3.1.4. Business Strategy 16.3.1.5. Recent Developments 16.3.1.6. Company Footprint 16.3.2. Pfizer 16.3.3. Eli Lilly 16.3.4. Merck Serono 16.3.5. F. Hoffmann-La Roche 16.3.6. Ferring Pharmaceuticals 16.3.7. GeneScience Pharmaceuticals 16.3.8. Ipsen 16.3.9. LG Life Sciences 16.3.10. Sandoz International 16.3.11. Anhui Anke Biotechnology 16.3.12. BioPartners 16.3.13. Teva Pharmaceutical Industries. 16.3.14. Novo Nordisk A/S 16.3.15. EMD Serono Inc. 16.3.16. AnkeBio Co. Ltd. 16.3.17. Genentech Inc. 17. Primary Key Insights

About This Report

Report ID37992
Category Healthcare
Published DateNov 2019
Updated DateNov 2020
Contact Us